These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 21945444

  • 1. Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer.
    Ueyama H, Horibe T, Nakajima O, Ohara K, Kohno M, Kawakami K.
    Biochem Biophys Res Commun; 2011 Oct 14; 414(1):60-6. PubMed ID: 21945444
    [Abstract] [Full Text] [Related]

  • 2. Localization of the anti-cancer peptide EGFR-lytic hybrid peptide in human pancreatic cancer BxPC-3 cells by immunocytochemistry.
    Ohara K, Kohno M, Kawakami K.
    J Pept Sci; 2013 Aug 14; 19(8):511-5. PubMed ID: 23813780
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library.
    Liang WC, Dennis MS, Stawicki S, Chanthery Y, Pan Q, Chen Y, Eigenbrot C, Yin J, Koch AW, Wu X, Ferrara N, Bagri A, Tessier-Lavigne M, Watts RJ, Wu Y.
    J Mol Biol; 2007 Feb 23; 366(3):815-29. PubMed ID: 17196977
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gene expression of neuropilin-1 and its receptors, VEGF/Semaphorin 3a, in normal and cancer cells.
    Haixia D, Jingsong Z, Lei J, Hairong D, Jun W, Hang X, Weixian C.
    Cell Biochem Biophys; 2011 Jan 23; 59(1):39-47. PubMed ID: 20711684
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent.
    Gioelli N, Maione F, Camillo C, Ghitti M, Valdembri D, Morello N, Darche M, Zentilin L, Cagnoni G, Qiu Y, Giacca M, Giustetto M, Paques M, Cascone I, Musco G, Tamagnone L, Giraudo E, Serini G.
    Sci Transl Med; 2018 May 23; 10(442):. PubMed ID: 29794061
    [Abstract] [Full Text] [Related]

  • 15. Semaphorin 3A displays a punctate distribution on the surface of neuronal cells and interacts with proteoglycans in the extracellular matrix.
    De Wit J, De Winter F, Klooster J, Verhaagen J.
    Mol Cell Neurosci; 2005 May 23; 29(1):40-55. PubMed ID: 15866045
    [Abstract] [Full Text] [Related]

  • 16. Neuropilin 1 directly interacts with Fer kinase to mediate semaphorin 3A-induced death of cortical neurons.
    Jiang SX, Whitehead S, Aylsworth A, Slinn J, Zurakowski B, Chan K, Li J, Hou ST.
    J Biol Chem; 2010 Mar 26; 285(13):9908-9918. PubMed ID: 20133938
    [Abstract] [Full Text] [Related]

  • 17. Selective requirements for NRP1 ligands during neurovascular patterning.
    Vieira JM, Schwarz Q, Ruhrberg C.
    Development; 2007 May 26; 134(10):1833-43. PubMed ID: 17428830
    [Abstract] [Full Text] [Related]

  • 18. Neuropilin-1 Acts as a Receptor for Complement Split Products.
    Battin C, De Sousa Linhares A, Paster W, Isenman DE, Wahrmann M, Leitner J, Zlabinger GJ, Steinberger P, Hofer J.
    Front Immunol; 2019 May 26; 10():2209. PubMed ID: 31572401
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.